inDex
abnormality. See normalcy
activist groups. See social movements
advertorials, 63–65, 122, 186–87
agenda setting, 167
Alexander, Tom, 50–52, 54, 183
algorithms, diagnostic and treatment, 58–
62, 78, 85, 172
alienated science, 96–98
alternative healthcare, 85, 198, 213
Althusser, Louis, 62, 68, 229n45
American Civil Liberties Union, 212
American Diabetes Association, 115, 168,
169
American Heart Association, 194
amplification of facts and opinions, 39, 60,
75, 84, 107–8, 120, 158, 183, 230n16
Angell, Marcia, 10
Appadurai, Arjun, 28
Aronowitz, Robert, 13
Astroturfing, 44
asymptomatic conditions, 13, 69, 84, 168–
70
Avorn, Jerry, 10
awareness campaigns, 7, 10, 35, 42–43, 55–
66, 69, 71, 79, 97, 120–25, 144, 162–63,
169, 184, 187, 189
Bartfai, Tamas, 91, 95–96, 100, 103, 177,
178
Beck, Ulrich, 80, 182
Beck- Gernsheim, Elizabeth, 7
Biehl, João, 185
bioavailability, 176
biocapital, 102
biomarkers, 4, 114, 127, 138, 158–60, 163,
167, 188, 199–202
biopolitics, 227n21
biotechnical embrace, the, 44, 222n5
blockbuster drugs, 57, 90–92, 133, 163,
209–11, 227n9
Bolling, Jay, 15, 65, 77, 83, 181
brands, pharmaceutical, 41, 83–84, 94, 181
Brandt, Allan, 107–9
Braverman, Paul, 193
breast cancer movement, 35, 42–43
Breast Cancer Prevention Trial, the, 142–44
Breitstein, Joanna, 64, 166–69
Burke, Kenneth, 73
Burns, Lawton R., 93
Califf, Robert, 102
Canguilhem, Georges, 123, 133, 152, 195
Cantone, Catherine, 43
Cartwright, Elizabeth, 173
Castel, Robert, 78, 133
Charan, Ram, 156
checklists, 72, 77–80, 136
chronic conditions, diseases, illnesses, or
treatments, 5–7, 14, 111, 115, 128, 140,
170, 174–79, 194, 206, 215
Previous Page Next Page